These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14998333)

  • 1. Design, synthesis, and evaluation of novel thienopyrrolizinones as antitubulin agents.
    Lisowski V; Léonce S; Kraus-Berthier L; Sopková-de Oliveira Santos J; Pierré A; Atassi G; Caignard DH; Renard P; Rault S
    J Med Chem; 2004 Mar; 47(6):1448-64. PubMed ID: 14998333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzopyridooxathiazepine derivatives as novel potent antimitotic agents.
    Gallet S; Flouquet N; Carato P; Pfeiffer B; Renard P; Léonce S; Pierré A; Berthelot P; Lebegue N
    Bioorg Med Chem; 2009 Feb; 17(3):1132-8. PubMed ID: 19162484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of novel pyrrolopyrrolizinones as anticancer agents.
    Rochais C; Lisowski V; Dallemagne P; Rault S
    Bioorg Med Chem; 2006 Dec; 14(24):8162-75. PubMed ID: 17011196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
    Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
    J Med Chem; 2006 Dec; 49(26):7816-25. PubMed ID: 17181164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and antiproliferative activity of tripentones: a new series of antitubulin agents.
    Lisowski V; Enguehard C; Lancelot J; Caignard D; Lambel S; Leonce S; Pierre A; Atassi G; Renard P; Rault S
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2205-8. PubMed ID: 11514171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-substituted 7-phenyl-pyrroloquinolinones show potent cytotoxic activity in human cancer cell lines.
    Gasparotto V; Castagliuolo I; Ferlin MG
    J Med Chem; 2007 Nov; 50(22):5509-13. PubMed ID: 17915851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
    Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
    J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
    Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
    J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.
    Liou JP; Chang YL; Kuo FM; Chang CW; Tseng HY; Wang CC; Yang YN; Chang JY; Lee SJ; Hsieh HP
    J Med Chem; 2004 Aug; 47(17):4247-57. PubMed ID: 15293996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CKD-516: a potent tubulin polymerization inhibitor with marked antitumor activity against murine and human solid tumors.
    Lee J; Kim SJ; Choi H; Kim YH; Lim IT; Yang HM; Lee CS; Kang HR; Ahn SK; Moon SK; Kim DH; Lee S; Choi NS; Lee KJ
    J Med Chem; 2010 Sep; 53(17):6337-54. PubMed ID: 20690624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel benzopyridothiadiazepines as potential active antitumor agents.
    Lebegue N; Gallet S; Flouquet N; Carato P; Pfeiffer B; Renard P; Léonce S; Pierré A; Chavatte P; Berthelot P
    J Med Chem; 2005 Nov; 48(23):7363-73. PubMed ID: 16279796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
    Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
    J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.
    Kuo CC; Hsieh HP; Pan WY; Chen CP; Liou JP; Lee SJ; Chang YL; Chen LT; Chen CT; Chang JY
    Cancer Res; 2004 Jul; 64(13):4621-8. PubMed ID: 15231674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents.
    Gurjar MK; Wakharkar RD; Singh AT; Jaggi M; Borate HB; Shinde PD; Verma R; Rajendran P; Dutt S; Singh G; Sanna VK; Singh MK; Srivastava SK; Mahajan VA; Jadhav VH; Dutta K; Krishnan K; Chaudhary A; Agarwal SK; Mukherjee R; Burman AC
    J Med Chem; 2007 Apr; 50(8):1744-53. PubMed ID: 17373779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
    Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
    J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro and in vivo antitumor activity of 2-phenylpyrroloquinolin-4-ones.
    Ferlin MG; Chiarelotto G; Gasparotto V; Dalla Via L; Pezzi V; Barzon L; Palù G; Castagliuolo I
    J Med Chem; 2005 May; 48(9):3417-27. PubMed ID: 15857148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anti-tumor activities of novel methylthio-, sulfinyl-, and sulfonyl-8H-thieno[2,3-b]pyrrolizin-8-oximino derivatives.
    Guo S; Zhao Y; Zhao X; Zhang S; Xie L; Kong W; Gong P
    Arch Pharm (Weinheim); 2007 Aug; 340(8):416-23. PubMed ID: 17628032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
    J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
    Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
    Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfonate derivatives of naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-anthracenone as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
    Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
    J Med Chem; 2007 Nov; 50(24):6059-66. PubMed ID: 17973361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.